Terns Pharmaceuticals, Inc. (TERN)
NASDAQ: TERN · Real-Time Price · USD
5.60
-0.31 (-5.25%)
At close: Nov 20, 2024, 4:00 PM
5.72
+0.12 (2.14%)
After-hours: Nov 20, 2024, 6:44 PM EST
Terns Pharmaceuticals Market Cap
Terns Pharmaceuticals has a market cap or net worth of $475.66 million as of November 21, 2024. Its market cap has increased by 58.62% in one year.
Market Cap
475.66M
Enterprise Value
104.19M
1-Year Change
58.62%
Ranking
Category
Stock Price
$5.60
Market Cap Chart
Since the IPO on February 5, 2021, Terns Pharmaceuticals's market cap has increased from $143.61M to $475.66M, an increase of 231.21%. That is a compound annual growth rate of 37.14%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2024 | 475.66M | 18.60% |
| Dec 29, 2023 | 401.05M | -20.44% |
| Dec 30, 2022 | 504.08M | 182.17% |
| Dec 31, 2021 | 178.64M | 24.39% |
| Feb 5, 2021 | 143.61M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SI-BONE | 514.79M |
| Monte Rosa Therapeutics | 512.38M |
| Pharming Group | 509.63M |
| Corvus Pharmaceuticals | 503.54M |
| GRAIL | 500.99M |
| GH Research | 498.95M |
| Community Health Systems | 497.80M |
| Third Harmonic Bio | 496.09M |